Your browser doesn't support javascript.
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
Oymak, Yesim; Karapinar, Tuba H; Devrim, Ilker.
  • Oymak Y; Departments of Pediatric Hematology and Oncology.
  • Karapinar TH; Departments of Pediatric Hematology and Oncology.
  • Devrim I; Pediatric Infectious Diseases, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
J Pediatr Hematol Oncol ; 43(1): 35-36, 2021 01.
Article in English | MEDLINE | ID: covidwho-977416

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / COVID-19 Drug Treatment / Glucosephosphate Dehydrogenase Deficiency / Hydroxychloroquine Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: J Pediatr Hematol Oncol Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / COVID-19 Drug Treatment / Glucosephosphate Dehydrogenase Deficiency / Hydroxychloroquine Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: J Pediatr Hematol Oncol Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article